Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (481-490 of 894) with videos related to

Pageof 90
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2012
Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in miceCarlamaria Zoja, Monica Locatelli, Chiara Pagani, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 5, 2026
4th workshop purification therapies, from research to clinics "the end of the beginning": executive summaryMauro Atti, Giuseppe Remuzzi, Giuseppe Feltrin, et al.
Frontiers in Pharmacology|March 17, 2022
Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19Valentina Fanny Leone, Amantia Imeraj, Sara Gastoldi, et al.
Diabetes|September 2, 2009
Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICTSalvatore De Cosmo, Nicola Motterlini, Sabrina Prudente, et al.
Diabetes|April 29, 2006
Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretionAneliya I Parvanova, Roberto Trevisan, Ilian P Iliev, et al.
Nephron|February 13, 2020
Morphofunctional Effects of C5 Convertase Blockade in Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Report of Two Cases with Evidence of Terminal Complement ActivationCamillo Carrara, Manuel Alfredo Podestà, Mauro Abbate, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 8, 2008
Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathyPiero Ruggenenti, Paolo Cravedi, Maria Chiara Sghirlanzoni, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 24, 2024
Reliability of GFR Estimated by Creatinine-Based Formulas in Moderate-to-Severe ProteinuriaCarmine Zoccali, Pasquale Fabio Provenzano, Giovanni Tripepi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 23, 2004
Therapeutic drug monitoring of sirolimus: effect of concomitant immunosuppressive therapy and optimization of drug dosingDario Cattaneo, Simona Merlini, Marisa Pellegrino, et al.
Kidney International|October 22, 2004
Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathyAriela Benigni, Carla Zoja, Cristina Zatelli, et al.
Pageof 90

Showing results (481-490 of 894) with videos related to

Sort By:
Pageof 90
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2012
Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in miceCarlamaria Zoja, Monica Locatelli, Chiara Pagani, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 5, 2026
4th workshop purification therapies, from research to clinics "the end of the beginning": executive summaryMauro Atti, Giuseppe Remuzzi, Giuseppe Feltrin, et al.
Frontiers in Pharmacology|March 17, 2022
Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19Valentina Fanny Leone, Amantia Imeraj, Sara Gastoldi, et al.
Diabetes|September 2, 2009
Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICTSalvatore De Cosmo, Nicola Motterlini, Sabrina Prudente, et al.
Diabetes|April 29, 2006
Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretionAneliya I Parvanova, Roberto Trevisan, Ilian P Iliev, et al.
Nephron|February 13, 2020
Morphofunctional Effects of C5 Convertase Blockade in Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Report of Two Cases with Evidence of Terminal Complement ActivationCamillo Carrara, Manuel Alfredo Podestà, Mauro Abbate, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 8, 2008
Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathyPiero Ruggenenti, Paolo Cravedi, Maria Chiara Sghirlanzoni, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 24, 2024
Reliability of GFR Estimated by Creatinine-Based Formulas in Moderate-to-Severe ProteinuriaCarmine Zoccali, Pasquale Fabio Provenzano, Giovanni Tripepi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 23, 2004
Therapeutic drug monitoring of sirolimus: effect of concomitant immunosuppressive therapy and optimization of drug dosingDario Cattaneo, Simona Merlini, Marisa Pellegrino, et al.
Kidney International|October 22, 2004
Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathyAriela Benigni, Carla Zoja, Cristina Zatelli, et al.
Pageof 90